Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,419.50 +31.95 0.21%
S&P 500 1,670.82 +1.66 0.10%
Nasdaq 3,509.23 +7.11 0.20%
Ticker Volume Price Price Delta
STOXX 50 2,812.37 -9.28 -0.33%
FTSE 100 6,814.42 +10.55 0.16%
DAX 8,464.37 -7.83 -0.09%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: NASDAQ GM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Amarin Corp PLC

+ Add to Watchlist

AMRN:US

7.1701 USD 0.1901 2.72%

As of 09:35:17 ET on 05/22/2013.

Company Profile for Amarin Corp PLC (AMRN)

Amarin Corporation PLC develops, manufactures, and distributes biopharmaceutical therapeutics. The Company markets its products used in the treatment of cardiovascular diseases to healthcare providers, clinics, researchers, and facilities throughout the world.

Contact Information

Amarin Corp PLC

Block 3, The Oval
Shelbourne Road, Ballsbridge
Dublin 4
Ireland
Phone: 353-1-669-9020

Key Executives for Amarin Corp PLC (AMRN)

Joseph S Zakrzewski "Joe"Chairman/CEOJohn F TheroPresident/Asst Secy
Steven B Ketchum "Steve"Senior VP/Pres:Rsch & DevParesh SoniSenior VP/Head:Dev
Joseph T KennedySenior VP/Chief Compliance Ofcr/Secy/Gen CnslJoe BrunoDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil